Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study

被引:0
|
作者
Yong Hwa Eom
Chang IK Yoon
Young Joon Kang
Ye Won Jeon
机构
[1] Eunpyeong St. Mary’s Hospital,Division of Breast Surgery, Department of Surgery
[2] College of Medicine,Division of Breast Surgery, Department of Surgery
[3] The Catholic University of Korea,Division of Breast Surgery, Department of Surgery
[4] Seoul St. Mary’s Hospital,Division of Breast Surgery, Department of Surgery, St. Vincent’s Hospital, College of Medicine
[5] College of Medicine,undefined
[6] The Catholic University of Korea,undefined
[7] Incheon St. Mary’s Hospital,undefined
[8] College of Medicine,undefined
[9] The Catholic University of Korea,undefined
[10] The Catholic University of Korea,undefined
关键词
Breast cancer; Ipsilateral; Local recurrence; Luminal; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: Response, survival, and prognostic factors
    Gilabert, M.
    Esterni, B.
    Bertucci, F.
    Viens, P.
    Goncalves, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Capecitabine after Anthracycline and Taxane Exposure in HER2-negative Metastatic Breast Cancer Patients: Response, Survival and Prognostic Factors
    Gilaberti, Marine
    Bertucci, Francois
    Esterni, Benjamin
    Madroszyk, Anne
    Tarpin, Carole
    Jacquemier, Jocelyne
    Extra, Jean-Marc
    Viens, Patrice
    Goncalves, Anthony
    ANTICANCER RESEARCH, 2011, 31 (03) : 1079 - 1086
  • [23] Factors influencing the development of visceral metastasis of breast cancer: A retrospective multi-center study
    Bartmann, Catharina
    Diessner, Joachim
    Blettner, Maria
    Haeusler, Sebastian
    Janni, Wolfgang
    Kreienberg, Rolf
    Krockenberger, Mathias
    Schwentner, Lukas
    Stein, Roland
    Stueber, Tanja
    Woeckel, Achim
    Wischnewsky, Manfred
    BREAST, 2017, 31 : 66 - 75
  • [24] Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients -A retrospective study
    Liu, Qiuyue
    Qiu, Juan
    Lu, Qianrun
    Ma, Yujin
    Fang, Shu
    Bu, Bing
    Song, Lihua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study
    Liu, Jiaxuan
    Zhang, Jiayang
    Li, Huiping
    Song, Guohong
    Di, Lijun
    Jiang, Hanfang
    Yan, Ying
    Wang, Huan
    Wang, Jing
    Liu, Xiaoran
    Shao, Bin
    Li, Qiao
    BMC CANCER, 2025, 25 (01)
  • [26] CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer
    Sim, Sung Hoon
    Bae, Chang-Dae
    Kwon, Youngmi
    Hwang, Hai-Li
    Poojan, Shiv
    Hong, Hye-In
    Kim, Kyungtae
    Kang, Seo-Hee
    Kim, Han-Seong
    Um, Tae-Hyun
    Park, In Hae
    Lee, Keun Seok
    Jung, So-Youn
    Lee, Seeyoun
    Kang, Han-Sung
    Lee, Eun Sook
    Kim, Mi-Kyung
    Hong, Kyeong-Man
    Ro, Jungsil
    PLOS ONE, 2017, 12 (08):
  • [27] EVALUATION OF KI-67 AS INDEPENDENT RISK FACTOR AND ITS ROLE IN THE INCIDENCE OF LOCAL RECURRENCE/DISTANT METASTASIS IN LUMINAL A AND LUMINAL B (HER2 NEGATIVE) BREAST CANCER: A RETROSPECTIVE ANALYSIS FROM A SINGLE CANCER CENTER
    Mohamed, R. F.
    Abdelhameed, D. H.
    Abdeltawab, A.
    WORLD CANCER RESEARCH JOURNAL, 2023, 10
  • [28] Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
    Lingfeng Tang
    Xiujie Shu
    Gang Tu
    World Journal of Surgical Oncology, 20
  • [29] Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
    Tang, Lingfeng
    Shu, Xiujie
    Tu, Gang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [30] Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors
    Yamada, Yoko
    Mukai, Hirofumi
    Tokudome, Yuta
    Kaneko, Motoko
    Kashiwabara, Kosuke
    Wada, Noriaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (03) : 248 - 254